chemie.pr-ots.at: das APA-OTS-Portal für multimediale Presseaussendungen
ots.at: das APA-OTS-Portal für multimediale Presseaussendungen.Presse Phase II Data on Lilly's Antibody Show It Affects Amyloid Beta, a Protein
Phase II Data on Lilly's Antibody Show It Affects Amyloid Beta, a Protein Believed To Be Associated with Alzheimer's Disease
30.07.2008 22:40:06
Eli Lilly and Company: Chicago (ots/PRNewswire) - - Findings lead to decision to start Phase III pivotal study of LY2062430 in 2009 Eli Lilly and Company (NYSE: LLY) today announced interim results of its Phase II study of LY2062430, an ...
Lesen Sie hier weiter... |
Drucken |
PDF
Ähnliche Artikel
- RVX-208 Exploratory Study Illustrates Early Potential for Alzheimer's Disease
- Alzheimer's Disease International (ADI)(1) Launches Worldwide Campaign to Address Growing Public Health and Social Care Emergency
- SCAI: SYNTAX Data Show PCI Is a Good Option for Patients With Complex Coronary Artery Disease
- Phase 3 Data Indicate Investigational 13-valent Vaccine May Broaden Protection Against Pneumoccocal Disease in Children Younger than Two
- Study Confirms That Avastin Significantly Increases Chance of Living Without Disease Progression in Metastatic Breast Cancer
- TMC278 Demonstrates Long-Term Efficacy and Tolerability in Treatment-Naïve Adults With HIV
- New Data Demonstrates Joint Damage is Inhibited With Wyeth's Biologic Enbrel(R) Plus Methotrexate in Patients With Early Active Rheumatoid Arthritis
- New Pegasys Data Show Hepatitis B Patients Achieve Highly Positive Treatment Response That Comes as Close to a Cure as Possible
- Largest-Ever Studies on Most Common Form of Adult Leukemia, Show Patients Treated With MabThera Live Longer Without Disease Progressing
- New Data Support Routine Childhood Vaccination With PREVENAR in Europe
Presseportal: Eli Lilly and Company - Lilly Oncology plant starken ...
Phase II Data on Lilly's Antibody Show It Affects Amyloid Beta, a Protein Believed To Be Associated with Alzheimer's Disease
Pressemitteilungen und Pressemeldungen vom 30.07.2008 | PresseEcho.de
News.Taeglich aktuelle Meldungen aus Bereichen wie Finanzen, Wirtschaft, Computer & IT, Sport Phase II Data on Lilly's Antibody Show It Affects Amyloid
Presseportal: Meldung versenden
Phase II Data on Lilly's Antibody Show It Affects Amyloid Beta, a Protein Believed To Be Associated with E-Mail-Adresse des Empfängers: Sie können max.5
Presseportal.de - Eli Lilly and Company
Phase II Data on Lilly's Antibody Show It Affects Amyloid Beta, a Protein Believed To Be Associated Phase III Trial for Treatment of Alzheimer's Disease